Dorothy Brach

Title: The Innovative Contributions of Dorothy Brach

Introduction

Dorothy Brach is a notable inventor based in Cambridge, MA (US), recognized for her significant contributions to cancer treatment. With a focus on innovative therapies, she has made strides in the medical field, particularly in the development of combination therapies for cancer.

Latest Patents

Dorothy Brach holds 1 patent for her work on a combination therapy for treating cancer. This patent discloses methods and compounds for the treatment of cancer, which involve administering a first agent in a therapeutically effective amount alongside one or more second agents. In specific embodiments, the first agent is an EZH2 inhibitor, such as tazemetostat or a pharmaceutically acceptable salt thereof. The methods outlined in her patent are particularly aimed at treating lung cancer, including non-small cell lung cancer.

Career Highlights

Dorothy Brach is currently associated with Epizyme, Inc., a company dedicated to developing innovative cancer therapies. Her work at Epizyme has positioned her as a key player in the fight against cancer, contributing to advancements that may improve patient outcomes.

Collaborations

Dorothy collaborates with Maria Alejandra Raimondi, who is also a prominent figure in the field. Their partnership exemplifies the collaborative spirit that drives innovation in medical research.

Conclusion

Dorothy Brach's contributions to cancer treatment through her innovative patent and work at Epizyme, Inc. highlight her role as a significant inventor in the medical field. Her dedication to improving cancer therapies continues to inspire advancements in healthcare.